Delivery Order SPE2DB24D1205-SPE2DB24FCSAT
Award Date 6/14/24
Potential Completion Date 6/17/24
Potential Value $22K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,130.32 firm fixed price delivery order is for the supply of the pharmaceutical product glycopyrrolate injection. The contract has an ultimate completion date of July 7, 2023. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a delivery order contract valued at $3,925.09 for the supply of GLYCOPYRROLATE INJECT. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
- This federal contract award is for the delivery of GLYCOPYRROLATE INJECT medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical, a major customer of prime contractor Amerisourcebergen Drug Corp. The $1,250.08 firm fixed price delivery order contract has an ultimate completion date of August 9, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these medical products under a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,455.52 Firm Fixed Price Delivery Order is for the supply of the pharmaceutical product Glycopyrrolate Injection. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $8,157.56 firm fixed price delivery order is for the supply of the pharmaceutical product glycopyrrolate injection. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
- This contract award is for the delivery of glycopyrrolate 0.2 mg/ml vials with a 5 ml capacity to the Defense Logistics Agency (DLA). The $2,337.48 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with no set-aside designation. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical through November 2026. This IDC serves as a...
- This is a federal contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.2 mg/ml glycopyrrolate vial with a 2 ml volume. The contract has a ceiling value of $16,735.09 and is a firm fixed price delivery order. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,241.53 fixed-price contract is for the delivery of Glycopyrrolate 0.2 mg/ml vial, a medication used to treat certain conditions. The contract has a completion date of June 12, 2025 and is not set aside for any specific business category. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award, valued at $3,955.74, was issued by the Medical Supply Chain division of the Defense agency to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of GLYCOPYRROLATE 0.2 MG/ML VIAL 20ML. The contract was awarded on a Firm Fixed Price basis with an ultimate completion date of April 24, 2024. Amerisourcebergen Drug Corp holds two Indefinite Delivery Contracts (IDCs) relevant to this award - a single-award IDC with the Defense Logistics...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $21,501.64 firm fixed-price delivery order contract is for the provision of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract has an ultimate completion date of March 25, 2025. Amerisourcebergen holds a...